Noetik - About the company
Noetik is a series A company based in San Francisco (United States), founded in 2022 by Ron Alfa. It operates as a Developer of AI-driven platform for cancer immunotherapy discovery and development. Noetik has raised $62M in funding from Polaris Partners and DCVC. The company has 31 active competitors, including 11 funded and 2 that have exited. Its top competitors include companies like Waypoint, Pathos and Predictive Oncology.
Company Details
Developer of AI-driven platform for cancer immunotherapy discovery and development. It leverages advanced machine learning to discover and develop cancer immunotherapies. The company uses AI to achieve what humans cannot do in the realm of tumor-immune interaction analysis. It combines self-supervised learning with human multimodal data generation to create foundation models for cell and tissue biology, driving therapeutic development.
- Website
- www.noetik.ai/
- Social
- Email ID
- *****@noetik.ai
Key Metrics
Founded Year
2022
Location
San Francisco, United States
Stage
Series A
Total Funding
$62M in 3 rounds
Latest Funding Round
Investors
Ranked
1st among 31 active competitors
Employee Count
53 as on Jun 30, 2026
Similar Companies
Sign up to download Noetik's company profile
Noetik's funding and investors
Noetik has raised a total funding of $62M over 3 rounds. Its first funding round was on Sep 12, 2022. Its latest funding round was a Series A round on Jul 31, 2024 for $*****. 16 investors participated in its latest round. Noetik has 15 institutional investors and 6 angel investors.
Here is the list of recent funding rounds of Noetik:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 31, 2024 | 5110791 | Series A | 9015513 | 3458191 | 9525094 | 3680650 |
Sep 07, 2023 | 4451850 | Seed | 7206768 | 9047426 | 9177436 | |
Sep 12, 2022 | 2119304 | Seed | 5504968 | 5126207 | 2804678 | 8377737 |
Access funding benchmarks and valuations. Sign up today!View details of Noetik's funding rounds and investors
Noetik's founders and board of directors
Founder? Claim ProfileThe founders of Noetik is Ron Alfa.
Here are the details of Noetik's key team members:
- Ron Alfa: Co-Founder & CSO of Noetik. Contact Info: 1 email address
View details of Noetik's Founder profiles and Board Members
Noetik's employee count trend
Noetik has 53 employees as of Jun 26. Here is Noetik's employee count trend over the years:
Uncover Noetik's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Noetik's Competitors and alternates
Top competitors of Noetik include Waypoint, Pathos and Predictive Oncology. Here is the list of Top 10 competitors of Noetik, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Noetik 2022, San Francisco (United States), Series A | Developer of AI-driven platform for cancer immunotherapy discovery and development | $62M | 62/100 | |
2nd |  Waypoint 2021, New York City (United States), Series A | Digital cell therapy platform for providers | $34.5M | 61/100 | |
3rd |  Pathos 2022, Chicago (United States), Series D | Provider of AI based drug discovery platform for drug development | $345M | 58/100 | |
4th |  Predictive Oncology 2002, Eagan (United States), Acquired | AI-based cancer diagnostic and precision medicines platform | $43M | 56/100 | |
5th |  Transition Bio 2020, Cambridge (United States), Series B | Developer of a technology platform for the analysis of biomolecular condensate | $69.3M | 55/100 | |
6th |  Econic Biosciences 2022, London (United Kingdom), Series B | Developer of a platform for the discovery and development of targeted therapies for cancer | $20M | 48/100 | |
7th |  Function Oncology 2018, San Diego (United States), Series A | Developer of therapeutics to treat cancer | $28M | 45/100 | |
8th |  Tailor Bio 2020, Cambridge (United Kingdom), Funding Raised | Developer of targeted therapies for cancers with chromosomal instability | - | 42/100 | |
9th |  Meliora Therapeutics 2021, San Francisco (United States), Seed | Provider of machine learning-driven drug discovery platform for cancer | $11M | 42/100 | |
10th | Developer of a device for in vitro cancer testing using a microfluidic chip | $11.2M | 42/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Noetik's competitors? Click here to see the top ones
Noetik's Investments and acquisitions
Noetik has made no investments or acquisitions yet.
Reports related to Noetik
Here is the latest report on Noetik's sector:
News related to Noetik
Media has covered Noetik for a total of 2 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
Bruker, Noetik Expand Collaboration, Advance Foundational Models for Therapeutics ApplicationsContract Pharma•Feb 24, 2026•Noetik, Bruker
•
AI Pharma Exclusive: GSK to Pay $50M to Use Noetik's AI Cancer ModelsEndpoints•Jan 08, 2026•Noetik, GSK
•
•
Noetik Announces First-in-Class Human Foundation Models for Discovery at SITC 2024Business Wire•Nov 07, 2024•Noetik
•
Noetik Selected to Participate in the 2024 AWS Generative AI AcceleratorBusiness Wire•Sep 12, 2024•Noetik
•
Noetik: AI-Based Biotech Company Raises $40 Million (Series A) To Develop Cancer TherapeuticsPulse 2.0•Sep 01, 2024•Noetik, Khosla Ventures, Wittington Ventures, Breakout Ventures and 10 others
•
Noetik raises $40M Series A to advance AI ambitions in cancer — with an unlikely lead investorEndPoints News•Aug 28, 2024•Noetik, Polaris Partners, Khosla Ventures, Wittington Ventures and 10 others
•
•
Noetik Raises $14 Million Seed Financing to Revolutionize Cancer Immunotherapy Using Artificial IntelligenceBusiness Wire•Sep 07, 2023•Noetik, DCVC, Zetta Venture Partners, 11.2 Capital and 5 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Noetik
Explore our recently published companies
- Serge Mashkevski - Unfunded company
- RC Best Choice - Markham based, Unfunded company
- Beattiesagri - United Kingdom based, 2022 founded, Unfunded company
- JOHNSON FUNERAL HOME AND CREMATORY - United States based, 1920 founded, Unfunded company
- Araamat - Estonia based, Unfunded company
- drivestore - Netherlands based, Public company
